ReviewFrontiers in public health2026
Adipose tissue: an overlooked target of medical ionizing radiation and its metabolic consequences.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite extensive research on radiation effects on various tissues, the impact on adipose tissue remains largely unexplored. This represents a critical knowledge gap given adipose tissue's role as an active endocrine organ and the extensive use of ionizing radiation in medical procedures. This review synthesizes the current evidence regarding the effects of ionizing radiation on adipose tissue pathophysiology, examining molecular mechanisms and clinical implications for metabolic health. We comprehensively reviewed studies investigating radiation effects on adipocytes and adipose-derived stem cells (ADSCs), analyzing different radiation energies, dose rates, and exposure timeframes. Converging evidence demonstrates that different dose protocols with ionizing radiation induce heterogeneous effects on adipose tissue cell number and size, pro-inflammatory secretome, and ADSCs functionality. Clinical studies in childhood cancer survivors reveal strong associations between abdominal radiation exposure and subsequent metabolic dysregulation, including insulin resistance and diabetes. Mechanistic studies suggest radiation-induced oxidative stress, impaired adipogenesis, and altered adipokine secretion as key pathways. Overall, ionizing radiation disrupts adipose tissue function through multiple molecular pathways, potentially predisposing individuals to long-term endocrine and metabolic dysfunctions. Elucidating the underlying mechanisms will contribute to optimize radiation therapy protocols and guide the development of targeted strategies to preserve metabolic health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.